NCT06967285 (PRONEBRAINAR) is a clinical trial of Prone ventilation in ARDS (Moderate or Severe), sponsored by Sichuan Provincial People's Hospital.

Who is sponsoring NCT06967285?

NCT06967285 is sponsored by Sichuan Provincial People's Hospital.

What drugs are being tested in NCT06967285?

Interventions in NCT06967285: Prone ventilation.

What condition does NCT06967285 study?

NCT06967285 studies ARDS (Moderate or Severe).

Is NCT06967285 still recruiting?

NCT06967285 is currently recruiting now. Last updated 13 May 2025.

Last reviewed 2025-05-13 · How we verify

NCT06967285: PRONEBRAINAR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prone Positioning in ARDS: Predicting Neurological Complications Via Cerebral Hemodynamics

Recruiting now Last updated 13 May 2025

What this trial tests

trial testing Prone ventilation in ARDS (Moderate or Severe) in 50 participants. Currently enrolling.

Timeline

19 March 2025

Primary endpoint
1 April 2026

1 April 2026

Quick facts

Lead sponsor	Sichuan Provincial People's Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	50
Start date	19 March 2025
Primary completion	1 April 2026
Estimated completion	1 April 2026
Sites	1 location across China

Drugs / interventions tested

Prone ventilation

Conditions studied

ARDS (Moderate or Severe) — all drugs for ARDS (Moderate or Severe) →

Sponsor

Sichuan Provincial People's Hospital

Who can join

18 and older, any sex, with ARDS (Moderate or Severe). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prone Positioning in ARDS: Predicting Neurological Complications via Cerebral Hemodynamics

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for ARDS (Moderate or Severe)

Currently open trials in the same condition.

NCT07176624 — The PRE-VAIL Study · NA · recruiting

Other Sichuan Provincial People's Hospital trials

Trials by the same sponsor.

NCT07298525 — Safety Exploration and Evaluation of Dexmedetomidine Hydrochloride Nasal Spray for Pre-anesthesia Sedation in Low-Monito · Phase 4 · not yet recruiting
NCT07175363 — Butorphanol for Pain Relief After Cesarean Section: A Retrospective Study · not yet recruiting
NCT07106996 — Mechanism of Red Yeast Rice Regulating Intestinal Indole Metabolism Pathway to Improve Chronic Inflammation in Polycysti · EARLY_PHASE1 · recruiting
NCT07082946 — Mechanisms of Perioperative Systemic Inflammation in the Development of PND in Cirrhotic Patients · not yet recruiting
NCT06821633 — Investigating the Retardation Effect of OCTA-Guided Targeted Photocoagulation on the Progression of Non-Perfusion Areas · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06967285 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sichuan Provincial People's Hospital
Last refreshed: 13 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06967285.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing